Too many promises and too many delays. Agreed! And we should expect that to continue. Let's call it a "feature" of the company.
I have lowered my expectations to:
- no tangible progress in the Zeiss development in this half year (i.e. no completion of final studies, no real progress on FDA approval) and
- no booked revenue through MR solutions this quarter.
However I do believe the MR solutions product will get on stream within months, before Optiscan runs out of money, and so will tide the company over till the Zeiss product starts selling. I am confident the company will survive............................... to thrive in the future - I hope.
Too many promises and too many delays. Agreed! And we should...
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.020(12.5%) |
Mkt cap ! $150.3M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 18.0¢ | 15.5¢ | $37.32K | 230.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 18555 | 2 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| OIL (ASX) Chart |